Tags

Type your tag names separated by a space and hit enter

[Antigliadin, antireticulin, antiendomysium antibodies: value in the diagnosis and follow-up of celiac disease in children].
Arch Pediatr 1994; 1(2):181-5AP

Abstract

In recent years, the clinical spectrum of coeliac disease has changed and forms with mild aspecific symptoms are today frequent. Therefore many infants are submitted to jejunal biopsy in order to exclude coeliac disease or to allow an early diagnosis. This has led to a search for a simple and reliable diagnostic test of coeliac disease in order to limit the use of jejunal biopsy. Recent data suggest that the study of serum antigliadin, antireticulin and antiendomysium antibodies may possibly play the role. In this paper the working group on coeliac disease of the Groupe Francophone de Gastroentérologie et Nutrition Pédiatriques expresses its view on the place of the dosages of these antibodies in the diagnosis and follow up procedures of coeliac disease in infants and children. At the present time, although it allows a simplification of the procedures, these dosages are presently not sufficiently reliable to serve as a substitute of jejunal biopsy.

Authors+Show Affiliations

Service de médecine infantile D, CHU Purpan, Toulouse, France.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

fre

PubMed ID

7987448

Citation

Olives, J P., et al. "[Antigliadin, Antireticulin, Antiendomysium Antibodies: Value in the Diagnosis and Follow-up of Celiac Disease in Children]." Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie, vol. 1, no. 2, 1994, pp. 181-5.
Olives JP, Baudon JJ, Dabadie A, et al. [Antigliadin, antireticulin, antiendomysium antibodies: value in the diagnosis and follow-up of celiac disease in children]. Arch Pediatr. 1994;1(2):181-5.
Olives, J. P., Baudon, J. J., Dabadie, A., Fontaine, J. L., Lamireau, T., Morali, A., ... Touhami, M. (1994). [Antigliadin, antireticulin, antiendomysium antibodies: value in the diagnosis and follow-up of celiac disease in children]. Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie, 1(2), pp. 181-5.
Olives JP, et al. [Antigliadin, Antireticulin, Antiendomysium Antibodies: Value in the Diagnosis and Follow-up of Celiac Disease in Children]. Arch Pediatr. 1994;1(2):181-5. PubMed PMID: 7987448.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Antigliadin, antireticulin, antiendomysium antibodies: value in the diagnosis and follow-up of celiac disease in children]. AU - Olives,J P, AU - Baudon,J J, AU - Dabadie,A, AU - Fontaine,J L, AU - Lamireau,T, AU - Morali,A, AU - Rieu,D, AU - Sarles,J, AU - Schmitz,J, AU - Touhami,M, PY - 1994/2/1/pubmed PY - 2000/5/5/medline PY - 1994/2/1/entrez SP - 181 EP - 5 JF - Archives de pediatrie : organe officiel de la Societe francaise de pediatrie JO - Arch Pediatr VL - 1 IS - 2 N2 - In recent years, the clinical spectrum of coeliac disease has changed and forms with mild aspecific symptoms are today frequent. Therefore many infants are submitted to jejunal biopsy in order to exclude coeliac disease or to allow an early diagnosis. This has led to a search for a simple and reliable diagnostic test of coeliac disease in order to limit the use of jejunal biopsy. Recent data suggest that the study of serum antigliadin, antireticulin and antiendomysium antibodies may possibly play the role. In this paper the working group on coeliac disease of the Groupe Francophone de Gastroentérologie et Nutrition Pédiatriques expresses its view on the place of the dosages of these antibodies in the diagnosis and follow up procedures of coeliac disease in infants and children. At the present time, although it allows a simplification of the procedures, these dosages are presently not sufficiently reliable to serve as a substitute of jejunal biopsy. SN - 0929-693X UR - https://www.unboundmedicine.com/medline/citation/7987448/[Antigliadin_antireticulin_antiendomysium_antibodies:_value_in_the_diagnosis_and_follow_up_of_celiac_disease_in_children]_ L2 - http://www.diseaseinfosearch.org/result/1186 DB - PRIME DP - Unbound Medicine ER -